Enfusion, Inc. (NYSE:ENFN) Sees Significant Increase in Short Interest

Enfusion, Inc. (NYSE:ENFN - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,300,000 shares, a growth of 28.7% from the March 15th total of 1,010,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the short-interest ratio is presently 1.1 days. Approximately 3.3% of the company's shares are sold short.

Insider Activity at Enfusion

In other Enfusion news, CFO Bradley Herring sold 4,645 shares of Enfusion stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total value of $52,860.10. Following the transaction, the chief financial officer now owns 324,689 shares in the company, valued at $3,694,960.82. This trade represents a 1.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Oleg Movchan sold 2,790 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total value of $32,029.20. Following the sale, the chief executive officer now owns 643,299 shares of the company's stock, valued at approximately $7,385,072.52. The trade was a 0.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 66,223 shares of company stock valued at $754,778. Company insiders own 36.44% of the company's stock.

Institutional Trading of Enfusion

Several large investors have recently modified their holdings of ENFN. KLP Kapitalforvaltning AS purchased a new position in Enfusion in the fourth quarter valued at about $75,000. FNY Investment Advisers LLC purchased a new position in shares of Enfusion during the 1st quarter valued at approximately $111,000. Millennium Management LLC acquired a new stake in shares of Enfusion during the fourth quarter worth approximately $114,000. Harbor Capital Advisors Inc. raised its holdings in Enfusion by 30.2% in the first quarter. Harbor Capital Advisors Inc. now owns 10,201 shares of the company's stock valued at $114,000 after acquiring an additional 2,366 shares in the last quarter. Finally, Dark Forest Capital Management LP acquired a new position in Enfusion during the 4th quarter worth $128,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Stock Performance

Shares of ENFN stock traded up $0.05 during trading hours on Thursday, reaching $10.85. The company had a trading volume of 2,461,878 shares, compared to its average volume of 635,884. The stock's fifty day simple moving average is $11.07 and its 200 day simple moving average is $10.45. The company has a market capitalization of $1.40 billion, a P/E ratio of 271.29, a price-to-earnings-growth ratio of 1.85 and a beta of 0.92. Enfusion has a twelve month low of $7.83 and a twelve month high of $11.80.

Enfusion (NYSE:ENFN - Get Free Report) last posted its earnings results on Monday, March 3rd. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.03 by ($0.02). Enfusion had a return on equity of 6.67% and a net margin of 1.70%. The firm had revenue of $52.94 million for the quarter, compared to analyst estimates of $53.98 million. As a group, equities analysts expect that Enfusion will post 0.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, William Blair reaffirmed a "market perform" rating on shares of Enfusion in a research note on Monday, January 13th.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.